SEL1L and Ataxia: Importantly, we recently identified 4 pathogenic SEL1L-HRD1 ERAD variants in 11 patients from 4 families, which are characterized by infantile-onset developmental delay, intellectual disability, microcephaly, facial dysmorphisms, hypotonia, and/or ataxia (36–38).